Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine modified-release versus immediate-release pharmacokinetic crossover study in healthy volunteers
NL-OMON38936Phase 1Active, not recruiting
- Sponsor
- Servier
- Start
- May 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ivabradine in stable angina and chronic heart failure (CHF) (5 arms), sponsored by Servier. Primary endpoints: S 16257 plasma concentrations and Pharmacokinetic parameters. Started May 2013; status: active, not recruiting.
02
Drugs
ivabradine
03
Conditions
stable anginachronic heart failure (CHF)
Beyond the preview
Go deeper on NL-OMON38936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38936.